SAN FRANCISCO, January 16, 2025--Stem, Inc. (NYSE: STEM), a global leader in artificial intelligence (AI)-enabled clean energy software and services, today announced that its Board of Directors ...
Jan. 15, 2025 — While most known types of DNA damage are fixed by our cells' in-house DNA repair mechanisms, some forms of DNA damage evade repair and can persist for many years, new research ...
Stem, Inc. (STEM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...
After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes. California Institute for Regenerative Medicine, Neurona Therapeutics, Vertex ...